Skip to content
Skip to footer
Ontada
Search
Search
Home
Providers
Life Sciences
Company
Careers
News & Insights
Publications
Contact Us
Providers
Life Sciences
Company
Careers
News & Insights
Publications
Contact Us
More >
News & Press Archive
Ontada Names Christine Davis Its New President
September 25, 2023
Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer
June 04, 2023
Research to Be Presented at ISPOR 2023 Illuminates the Economic Costs of Melanoma and Non-Small Cell Lung Cancer and Provides Insights That Can Help Strengthen the Quality and Approach to Real-World Evidence Generation
May 05, 2023
How Can We Use Data to Mitigate the Impact of SDOH?
March 21, 2023
McKesson Designated by CMS as 2023 Qualified Clinical Data Registry
February 15, 2023
Diversity in Clinical Trials
February 14, 2023
Accelerating Progress in Precision Oncology
January 30, 2023
Pharma and RWE: Hitting Its Stride
December 08, 2022
McKesson Thought Leaders Are Key Presenters at 2022 Association for Value-Based Cancer Care Summit
October 18, 2022
Using Integrated EHR and Claims Data for a Holistic View of the Patient Journey
October 07, 2022
Using Data to Bring Hope to Patients
September 15, 2022
The Power of Using Real-World Evidence to Support Clinical Trials
September 06, 2022
Taking Action to Address Health Equity in Oncology
August 23, 2022
Data Stewardship | The privilege and responsibility of ensuring data quality and methodological rigor
August 22, 2022
Social Drivers of Health (SDOH): A Social Work Perspective
August 17, 2022
BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care
August 15, 2022
Expanding Opportunities for Real-World Evidence in Oncology
July 22, 2022
The Pharmacist’s Role in Oncology Clinical Trials With Beth Koselke, PharmD, BCOP
June 30, 2022
Connection Is Key to Improving Diversity in Clinical Trials
June 28, 2022
Examining Trends of Biomarker Testing With the MYLUNG Study in mNSCLC
June 23, 2022
A fireside chat with powerful cancer care advocate, Chris Draft, about changing the conversation around lung cancer
June 17, 2022
ASCO 2022: Achieving health equity in cancer care
June 16, 2022
Expert: Improving Disparities in Biomarker Testing Requires Involvement of Multiple Stakeholders
June 14, 2022
Oncology Pharmacist Helps Boost Patient Enrollment at Community Practices Engaging in MYLUNG Study
June 08, 2022
Expert Discusses Disparities in Biomarker Testing for NSCLC
June 06, 2022
Expert Discusses the Impact of Pharmacist Intervention in Clinical Trial Enrollment
June 06, 2022
New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology Setting
June 06, 2022
Investigators from US Oncology Research, The US Oncology Network and Ontada Present Data Highlighting Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting
June 03, 2022
ISPOR 2022: Putting the patient at the center
May 23, 2022
Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022
May 13, 2022
Oncology Innovation: Optimism & Obstacles
April 08, 2022
Real Talk from the Real World: A Q&A Series with Ontada’s leaders
April 04, 2022
5 Women Transforming Healthcare Through Technology
March 11, 2022
Real world data and FDA: Drugmakers seek more clarity on registry guidance
March 07, 2022
The Bright Future of Community Oncology
March 03, 2022
McKesson Designated by CMS as 2022 Qualified Clinical Data Registry
February 08, 2022
Ontada Names Dr. Nicholas Robert as Chief Medical Officer
February 07, 2022
Ontada Names Viraj Narayanan as Chief Commercial Officer
January 25, 2022
Combining IQ with EQ to support evidence-driven care
January 21, 2022
US Oncology Research, The US Oncology Network and Ontada Announce Data Presentations across Areas of Critical Need at 2021 American Society of Hematology Annual Meeting and Exposition
December 09, 2021
New Metrics Show The US Oncology Network Practices Leading the Way in Value-Based Care
November 16, 2021
Ontada Names Sagran Moodley as Chief Innovation and Technology Officer
November 03, 2021
The Evolution of Breast Cancer:
From Research to Treatment
September 28, 2021
Ontada Launches HOPE Studies, Empowering Oncologists to Leverage Real-World Data and Address Healthcare Disparities
September 15, 2021
Ontada Signs Strategic Agreement with Merck to Facilitate the Development of Data-Driven Insights to Impact Quality of Cancer Care
August 26, 2021
Lung Cancer Study Brings Pharmacists to the Forefront of Patient Care
June 15, 2021
First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research
June 04, 2021
US Oncology Research, The US Oncology Network and Ontada Announce Clinical Data Showcased in Plenary and Oral Sessions at ASCO Annual Meeting
June 03, 2021
At Ontada,
your work means more
April 24, 2021
New technology harnesses the power of biomarker-related data
March 25, 2021
Ontada Appoints Susan Shiff, Ph.D., MBA, as President
March 22, 2021
Work-life integration: From researcher to mom, and everything in between
March 11, 2021
3 imperatives to drive the EHR of the future
February 22, 2021
Why I’m with Ontada: The power of research
February 19, 2021
Ontada’s Clear Value Plus Provides 800,000th Chemotherapy Treatment Decision
February 18, 2021
Pragmatic Trials Offer Benefits in the Development of Precision Medicine for Lung Cancer
February 14, 2021
MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients
February 04, 2021
Overcoming the Challenges of Biomarker Testing
January 17, 2021
How Real-World Data is Helping Speed Oncology Drug Development
December 11, 2020
Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities
December 04, 2020
McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care
December 03, 2020
Meet Ontada
December 03, 2020
How to Leverage Real-World Data as COVID-19 Transforms Clinical Trials
October 27, 2020
Optimizing Benefit in Targeted Therapies Requires Multipronged Educational Approach
October 25, 2020
Using Real-World Data to Understand the Impact of COVID-19 on Oncology Patient Care
September 18, 2020
Cancer Care in the COVID-19 World: Adjusting to a New Reality
July 31, 2020
Ad Campaign Says Don’t Let COVID-19 Fear Delay Doctor Visits
July 07, 2020
McKesson Appoints Lyn Fitzgerald as Vice President of Sales for McKesson Data, Evidence & Insights
May 05, 2020
Real-World Evidence Should be Part of Clinical Trials in Oncology
March 28, 2020
Real-World Evidence at a Glance: How a Collaboration of “Frenemies” Produced Common Definitions for Real-World Endpoints
November 22, 2019
Learning to Harmonize: Ten Health Care Research Organizations Tell Us How They Formulated Common Definitions for Real-World Endpoints
November 22, 2019
Real-World Data, Evidence Should be Leveraged in Clinical Research to Better Include and Ultimately Treat Larger Patient Populations
October 18, 2019
McKesson and Aetion Collaborate to Advance Cancer Research with Real-World Data
October 15, 2019
McKesson Playing Pivotal Role in Phase II of Friends of Cancer Research Real-World Evidence Initiative
August 08, 2019
Dr. Nicholas Robert Discusses How Real-World Data Can Complement Clinical Trial Data
July 16, 2019
Dr. Nicholas Robert Explains the Benefits, Challenges of Using RWE for Measuring Clinical End Points
May 23, 2019
How Pharma Can Help Ease the Growing Burden on Healthcare Professionals
May 16, 2019
Implementing RWE to Advance Innovative Medicine
May 10, 2019
Rethinking the Use of Real-World Evidence to Improve Policy Decisions
April 19, 2019
The Scrutiny on Rebates and Prices will Change the Pharma Payer Relationship
April 15, 2019
AI Will Converge with Physician-Directed Care
January 05, 2019
FDA Framework Signals Openness to Real-World Evidence for Drug Approvals
December 13, 2018
Real-World Evidence (RWE): Advancing Both Clinical and Commercial Objectives
November 08, 2018
Current and Potential Significance of Real-World Data in Value-Based Outcomes, Compliance
September 24, 2018
Beyond Big Data: Meeting the Specialty Marketing Challenge
September 14, 2018
MCC Rx Marks First Use of Real-World Data for FDA Approval
September 13, 2018
Challenges with Treating Merkel Cell Carcinoma and Other Rare Diseases
July 01, 2018
Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
March 16, 2018
top
close